• 1
    Okamoto T. Oxidative stress in rheumatoid arthritis. In: SurhY-J, PackerL, eds. Oxidative stress, inflammation and health. Califórnia, CA: Taylor & Francis, 2005:24570.
  • 2
    Avalos I, Chung CP, Oeser A et al. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 2007; 16:195200.
  • 3
    Altindag O, Karakoc M, Kocyigit A, Celik H, Soran N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 2007; 40:16771.
  • 4
    Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2:189202.
  • 5
    Senna ER, De Barros AL, Silva EO et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31:5947.
  • 6
    Ozkan Y, Yardym-Akaydyn S, Sepici A, Keskin E, Sepici V, Simsek B. Oxidative status in rheumatoid arthritis. Clin Rheumatol 2007; 26:648.
  • 7
    Sies H. Oxidative Stress: Introductory Remarks. London: Academic Press, 1985.
  • 8
    Forman HJ, Fukuto JM, Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 2004; 287:C24656.
  • 9
    Jones DP. Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact 2006; 163:3853.
  • 10
    Roehrs R, Guecheva TN, Saffi J, Henriques JAP. Redox sensitive targets in signaling cascades. In: ULBRA, ed. Free radicals and the cellular response to the oxidative stress. Universidade Luterana do Brasil: Canoas, 2004:16184.
  • 11
    Barry Halliwell JG. Free radicals in biology and medicine, 4th edn. New York: Oxford University Press, 2007.
  • 12
    Griffiths HR. ROS as signalling molecules in T cells − evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep 2005; 10:27380.
  • 13
    Oktyabrsky ON, Smirnova GV. Redox regulation of cellular functions. Biochemistry (Mosc) 2007; 72:13245.
  • 14
    Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004; 6:26578.
  • 15
    Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82:4795.
  • 16
    Curi R PIHdB Jr. Arachdonic acid metabolism in sepsis. In: Manole, ed. São Paulo: SEPSE, 2007.
  • 17
    Soneja A, Drews M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep 2005; 57 (Suppl.):10819.
  • 18
    Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001; 81:20937.
  • 19
    Bar-Shai M, Reznick AZ. Reactive nitrogen species induce nuclear factor-kappaB-mediated protein degradation in skeletal muscle cells. Free Radic Biol Med 2006; 40:211225.
  • 20
    Ignarro LJ. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol 1989; 26:6376.
  • 21
    Blair IA. Endogenous glutathione adducts. Curr Drug Metab 2006; 7:85372.
  • 22
    Fritz R, Bol J, Hebling U et al. Compartment-dependent management of H(2)O(2) by peroxisomes. Free Radic Biol Med 2007; 42:111929.
  • 23
    Hwang ES, Kim GH. Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 2007; 229:110.
  • 24
    Aukrust P, Luna L, Ueland T, et al. Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. Blood 2005; 105:47305.
  • 25
    Asagoshi K, Odawara H, Nakano H, et al. Comparison of substrate specificities of Escherichia coli endonuclease III and its mouse homologue (mNTH1) using defined oligonucleotide substrates. Biochemistry 2000; 39:1138998.
  • 26
    Yang N, Galick H, Wallace SS. Attempted base excision repair of ionizing radiation damage in human lymphoblastoid cells produces lethal and mutagenic double strand breaks. DNA Repair (Amst) 2004; 3:132334.
  • 27
    Winterbourn CC, Buss IH. Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 1999; 300:10611.
  • 28
    Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15:31628.
  • 29
    Wong YT, Ruan R, Tay FE. Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats. Free Radic Res 2006; 40:393402.
  • 30
    Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 2001; 21:6973.
  • 31
    Andreoli TE, Bennett JC, Carpenter CCJ, Plum F. Medicina interna básica. Livro 1998; 1:56870.
  • 32
    McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7:42942.
  • 33
    Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118:458992.
  • 34
    Tak PP, Zvaifler NJ, Green DR, Firestein GS. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000; 21:7882.
  • 35
    Okamoto T, Sakurada S, Yang JP, Merin JP. Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. Curr Top Cell Regul 1997; 35:14961.
  • 36
    Grootveld M, Henderson EB, Farrell A, Blake DR, Parkes HG, Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J 1991; 273:45967.
  • 37
    Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular anti-oxidants, and anti-oxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002; 21:2004.
  • 38
    Dai L, Lamb DJ, Leake DS et al. Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid arthritis patients. Free Radic Res 2000; 32:47986.
  • 39
    Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003; 329:2338.
  • 40
    Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52:65966.
  • 41
    Maurice MM, Nakamura H, Gringhuis S et al. Expression of the thioredoxin–thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42:24309.
  • 42
    McInnes IB, Leung BP, Field M et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996; 184:151924.
  • 43
    Jikimoto T, Nishikubo Y, Koshiba M et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2002; 38:76572.
  • 44
    Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA. Anti-oxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003; 157:34554.
  • 45
    Hagfors L, Leanderson P, Skoldstam L, Andersson J, Johansson G. Anti-oxidant intake, plasma anti-oxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2003; 2:5.
  • 46
    Aaseth J, Haugen M, Forre O. Rheumatoid arthritis and metal compounds − perspectives on the role of oxygen radical detoxification. Analyst 1998; 123:36.
  • 47
    Comstock GW, Burke AE, Hoffman SC et al. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1997; 56:3235.
  • 48
    Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL. Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology 1996; 7:25663.
  • 49
    Jayson MI, Dixon AS. Intra-articular pressure in rheumatoid arthritis of the knee. 3. Pressure changes during joint use. Ann Rheum Dis 1970; 29:4018.
  • 50
    Cedergren J, Forslund T, Sundqvist T, Skogh T. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. J Rheumatol 2007; 34:216270.
  • 51
    Klareskog L, Padyukov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007; 19:4954.
  • 52
    Garcez M, D Bordin W Peres M Salvador. Free radicals and reactive species. In: Ulbra, ed. Free radicals and the cellular response to the oxidative stress. Canoas: Porto Alegre, 2004:1334.
  • 53
    McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974; 185:52931.
  • 54
    Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003; 11:74755.
  • 55
    Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990; 85:6329.
  • 56
    Goldring SR. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2002; 14:40610.
  • 57
    Miossec P. An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16:21822.
  • 58
    Gringhuis SI, Leow A, Papendrecht-Van Der Voort EA, Remans PH, Breedveld FC, Verweij CL. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 2000; 164:21709.
  • 59
    Bar-Shai M, Reznick AZ. Peroxynitrite induces an alternative NF-kappaB activation pathway in L8 rat myoblasts. Anti-oxid Redox Signal 2006; 8:63952.
  • 60
    Sakurada S, Kato T, Okamoto T. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Int Immunol 1996; 8:148393.
  • 61
    De Bandt M, Grossin M, Driss F, Pincemail J, Babin-Chevaye C, Pasquier C. Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum 2002; 46:52232.
  • 62
    Dai L, Claxson A, Marklund SL et al. Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther 2003; 10:5508.
  • 63
    Iyama S, Okamoto T, Sato T et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum 2001; 44:21607.
  • 64
    Salvemini D, Mazzon E, Dugo L et al. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum 2001; 44:290921.
  • 65
    Lee EY, Lee CK, Lee KU et al. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int 2007; 27:22533.
  • 66
    Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 2005; 57:16372.
  • 67
    Sung JY, Hong JH, Kang HS et al. Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology 2000; 47:3544.
  • 68
    Laurindo IM, Mello SB, Cossermelli W. Influence of low doses of methotrexate on superoxide anion production by polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Rheumatol 1995; 22:6338.
  • 69
    Herman S, Zurgil N, Deutsch M. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res 2005; 54:27380.
  • 70
    Den Broeder AA, Wanten GJ, Oyen WJ, Naber T, Van Riel PL, Barrera P. Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis. J Rheumatol 2003; 30:2327.
  • 71
    Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A. Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatol Int 2007; 28:24551.
  • 72
    Mangge H, Hermann J, Schauenstein K. Diet and rheumatoid arthritis − a review. Scand J Rheumatol 1999; 28:2019.